<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871244/" ref="ordinalpos=4963&amp;ncbi_uid=5683244&amp;link_uid=PMC3871244" image-link="/pmc/articles/PMC3871244/figure/F5/" class="imagepopup">Figure 5. WNT <span class="highlight" style="background-color:">pathway</span> deregulation in subgroup III tumors..  From: MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. </a></div><br /><div class="p4l_captionBody">Box plots show relative gene expression levels, and bee swarm plots show DNA methylation M-values, of genes encoding various inhibitors of the WNT signaling pathway, including Wnt inhibitory factor 1 (WIF1), secreted frizzled-related protein 1 (SFRP1), SFRP2, SFRP4, Dickkopf-related protein 2 (DKK2), and DKK3, in subgroup I (n = 19) and subgroup III (n = 23). Expression of WNT pathway inhibitors was significantly reduced in subgroup III tumors (Welch test). Data were collected using GeneChip Human Gene 1.0 ST arrays and Human Methylation 450 BeadChips. </div></div>